Moolec Science
MLEC
3 hedge funds and large institutions have $3.59K invested in Moolec Science in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2.22% less ownership
Funds ownership: 2.28% → 0.07% (-2.2%)
96% less capital invested
Capital invested by funds: $98K → $3.59K (-$94.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.76K |
| 2 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$80 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$98K |
MLEC Hedge Fund Activity: Q2 2026 in Review
3 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q2 2026, worth a combined $3.59K — down 96% from $98K a quarter earlier.
Fund positioning in MLEC was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $3.76K. The largest seller was HRT Financial, exiting entirely with an estimated $98K sold.
- 3 institutional investors held Moolec Science (MLEC) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $3.59K of Moolec Science stock for Q2 2026, down 96% quarter-over-quarter.
- 1 fund opened new Moolec Science positions in Q2 2026 and 1 closed out, a net change of 0 holders.
- The largest Moolec Science buyer in Q2 2026 was UBS Group, an estimated $3.76K added.
- The largest Moolec Science seller in Q2 2026 was HRT Financial, an estimated $98K sold.
Based on aggregated 13F filings for Q2 2026.